IHL 0.00% 4.1¢ incannex healthcare limited

Ann: IHL-42X positive phase 2 clinical trial results, page-382

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 617 Posts.
    lightbulb Created with Sketch. 103
    Hi @comincon quite possible a synagistic approach could be looked at. The respiratory and heart impacts from a seizure have similar outcomes with OSA where both breathing and heart rate increase prior to the breathing stopping. If a co-modulating effect from the OSA treatment reduces these aspects which is indicated by the recent data it is highly likely to reduce risk for where there is a central neural stop or is overloaded and breathing stops and then induces stress on the heart which may lead to a fibrilation issue. Just my opinion but worth taking up with someone above my pay level. I am sure that is why Terry O'Brien's inclusion of epilepsy end points were included particularly where there is a high of current drug resistance.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.